Reference Drug Signature Database Creation

The contract aims to generate and catalog high-fidelity spectral signatures of approved pharmaceuticals using gold-standard analytical techniques to build a reference database for training and validating artificial intelligence models. The work requires precise, reproducible measurements of drug molecular properties under controlled conditions to ensure the integrity and utility of the spectral data in downstream AI applications. The project demands expertise in advanced spectroscopy and rigorous quality control to meet the standards necessary for scientific and regulatory use. This subcontract, posted by the Advanced Research Projects Agency for Health under the U.S. Department of Health and Human Services, targets entities capable of executing complex analytical workflows with high accuracy. Performance is expected to be centered in the Washington D.C. area with a zip code of 20005, and responses must be submitted by August 20, 2026. The North American Industry Classification System code 541380 indicates the work falls under other scientific and technical consulting services, underscoring the need for specialized analytical and data management capabilities. The initiative is foundational in advancing AI-driven drug discovery and validation by establishing a trusted, standardized spectral library.